AtWork: The Relation Between Cognitive Functioning, Common Mental Disorders and Work Functioning
AtWork
1 other identifier
observational
200
1 country
1
Brief Summary
Depression and anxiety affects levels of function across different levels like work, increasing levels of sick leave and as well as cognitive functioning. In the current study patients at risk of sick leave with depression and anxiety receive metacognitive therapy and work focus in an ordinary outpatient clinic. Impaired cognitive functioning may also be of importance in the return to work process and degree of sick leave. It is important to get a better understanding of how cognitive functioning is related to sick leave and if it predicts return to work, and if cognitive functioning is changed due to psychological treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2032
January 21, 2026
January 1, 2026
5.6 years
June 17, 2025
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Patient Health Questionnaire-9 (PHQ-9)
Measure of depressive symptoms (PHQ-9) range 0-27 higher scores indicate higher degree of depressive symptoms
Measured at pre-treatment and at therapy completion, an average of 10 weekly sessions, and at 6, 12 months follow-up
Generalized Anxiety Disorder (GAD-7)
Anxiety symptoms (GAD-7) range 0-21 higher scores indicating higher degree of anxiety symptoms
Measured at pre-treatment and at therapy completion, an average of 10 weekly sessions, and at 6, 12 months follow-up
Changes in sick leave
Sick leave is collected from national register data measured in number of days of sick leave.
Measured at pre-treatment and at therapy completion, an average of 10 weekly sessions, and at 6, 12 months follow-up
Study Arms (1)
Patients referred with depression and/or anxiety and at risk of sick leave
Patients referred with depression and/or anxiety and at risk of sick leave
Eligibility Criteria
Patients referred with depression and/or anxiety disorders at risk of sick leave.
You may qualify if:
- diagnosis of depression and/or anxiety,
- at risk of sick leave
You may not qualify if:
- personality disorders cluster A or B,
- ongoing substance abuse,
- symptoms of psychosis,
- acute suicidality,
- serious somatic disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- The Research Council of Norwaycollaborator
- Diakonhjemmet Hospitalcollaborator
Study Sites (1)
Diakonhjemmet hospital
Oslo, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2025
First Posted
January 20, 2026
Study Start
January 1, 2024
Primary Completion (Estimated)
August 1, 2029
Study Completion (Estimated)
August 1, 2032
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Due to ethical considerations as this is a clinical study that includes patients with depression and/or anxiety at risk of sick leave, information will not be shared